Search

everythinglearnresearchcommunity

for

Search:↓

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Women with PCOS have more emotional and body image issues than healthy women.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Hair loss in postmenopausal woman caused by ovarian issue.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

We need better ways to test and understand SARMs to make safer and more effective treatments.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.